Histopathology report

• anatomical location of lymph node groups.

• weight (g) of tissue. Number of nodes identified. Number of lymph nodes involved by metastatic disease. Maximum diameter of largest involved node. Presence or absence of extra-nodal spread.

RPLNDs for non-seminomatous germ cell tumours post chemotherapy.

• presence of fibrosis, tumour necrosis or other effects of chemotherapy.

• presence or absence of residual viable tumour. Mature cystic teratomatous components, immature elements, malignancies of somatic components, i.e., carcinoma or sarcoma.

• presence or absence of residual viable embryonal carcinoma, yolk sac tumour or choriocar-cinoma.

• relationship to inked circumferential margin.

0 0

Post a comment